NSETrading Window2d ago · 23 Sept 2026, 02:45 pm
Trading Window
Entero Healthcare Solutions Limited · ENTERO
✦ AI SummaryRegulatory
Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company by the Designated Persons of the Company and their immediate relatives will be closed from October 1, 2026, and will remain closed up to 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ENTERO_23092026144501_SE_Intimation.pdf
View document text
Ref: 40/SE/LC/2026-27 Date: September 23, 2026
Scrip Code BSE: 544122
NSE: ENTERO
ISIN: INE010601016
Head, Listing Compliance Department Head, Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block,
Mumbai - 400001 Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051
Dear Sir/Madam,
Subject: Intimation of Closure of Trading Window
This is to inform you that pursuant to the Company’s Code of Fair Disclosure of Unpublished
Price Sensitive Information framed pursuant to the Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for
dealing in securities of the Company by the Designated Persons of the Company and their
immediate relatives will be closed with effect from October 01, 2026 and shall remain closed
up to 48 (Forty Eight) hours after declaration of the Unaudited Financial Results of the
Company for the quarter ended September 30, 2026.
The date of the Board Meeting to consider the aforesaid Unaudited Financial Results of the
Company will be intimated in due course of time.
This is for your information and records.
Yours Faithfully
For Entero Healthcare Solutions Limited
Sanu Kapoor
Vice President - Group General Counsel,
Company Secretary & Compliance Officer